1. Home
  2. CCIF vs LNSR Comparison

CCIF vs LNSR Comparison

Compare CCIF & LNSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CCIF

Carlyle Credit Income Fund Shares of Beneficial Interest

HOLD

Current Price

$2.68

Market Cap

57.2M

Sector

Finance

ML Signal

HOLD

Logo LENSAR Inc.

LNSR

LENSAR Inc.

N/A

Current Price

$9.10

Market Cap

106.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CCIF
LNSR
Founded
2011
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Medical Electronics
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
57.2M
106.6M
IPO Year
2011
2005

Fundamental Metrics

Financial Performance
Metric
CCIF
LNSR
Price
$2.68
$9.10
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$10.00
AVG Volume (30 Days)
115.8K
154.5K
Earning Date
01-01-0001
05-11-2026
Dividend Yield
25.90%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.61
Revenue
N/A
$58,435,000.00
Revenue This Year
N/A
$10.06
Revenue Next Year
N/A
$41.48
P/E Ratio
N/A
$15.13
Revenue Growth
N/A
9.24
52 Week Low
$2.57
$4.95
52 Week High
$5.95
$12.94

Technical Indicators

Market Signals
Indicator
CCIF
LNSR
Relative Strength Index (RSI) 42.84 78.80
Support Level $2.72 $5.25
Resistance Level $2.95 $12.13
Average True Range (ATR) 0.07 0.46
MACD -0.01 0.26
Stochastic Oscillator 11.67 96.25

Price Performance

Historical Comparison
CCIF
LNSR

About CCIF Carlyle Credit Income Fund Shares of Beneficial Interest

Carlyle Credit Income Fund is a non-diversified, closed-end management investment company. The Fund's primary investment objective is to generate current income, with a secondary objective to generate capital appreciation. The Fund seeks to achieve its investment objective by investing predominantly in equity and junior debt tranches of collateralized loan obligations, that are collateralized by a portfolio consisting mainly of below-investment-grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors.

About LNSR LENSAR Inc.

LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia (excluding South Korea), South Korea, and Other.

Share on Social Networks: